Ramy Farid; President, Chief Executive Officer, Director; Schrodinger Inc Geoffrey Porges; Chief Financial Officer, Executive Vice President; Schrodinger Inc Steve Dechert; Analyst; KeyBanc Capital ...

Q4 2024 Earnings Call Transcript November 12, 2024 Operator: Greetings and welcome to the Azenta Fourth Quarter 2024 ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, continues to empower parents with ...

Please note that all the information discussed on today's call is covered under the safe harbor provisions of the Private Securities ... AI is optimizing online car buying from discovery to final sale ...

Before we begin, I'd like to remind everyone that remarks about future expectations, plans, and prospects constitute ...

Before we begin, let me quickly cover the Safe Harbor. During this call ... In the near term, I see potential for transformative shifts in music discovery and new innovative ways to connect artists ...

(NYSEA:IBIO) today reported financial results for the fiscal first quarter ended September 30, 2024 and provided a corporate ...

Many of our programs are derived from our TRACER™ AAV capsid discovery platform ... This press release contains ...

Positive preliminary Phase 1b data in SEACRAFT-1 NRASm melanoma cohort bolsters conviction in ongoing SEACRAFT-2 registrational trial; Stage 1 ...

Announced Exclusive Licensing Agreement with Viatris for Sotagliflozin in all Markets Outside of the U.S. and Europe Completed ZYNQUISTA FDA Advisory Committee Meeting; PDUFA Goal Date December 20, 20 ...

Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025– Long-term azetukalner results from X-TOLE open-label ...